JPMorgan Maintains Neutral Rating on Xylem, Cuts Price Target to $118
JPMorgan cut its price target on Xylem to $118 per share from $137 while maintaining a Neutral rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.